[Mucoviscidosis. 22-year experience in daily practice].
D000336:Aerosols / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001660:Biliary Tract Diseases / Q000209:etiology; D001982:Bronchial Diseases / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D004700:Endocrine System Diseases / Q000209:etiology; D005260:Female; D006801:Humans; D007167:Immunotherapy; D007223:Infant; D007410:Intestinal Diseases / Q000209:etiology; D008171:Lung Diseases / Q000209:etiology; D008297:Male; D010182:Pancreatic Diseases / Q000209:etiology; D026741:Physical Therapy Modalities; D012917:Social Adjustment
D000336:Aerosols; D000900:Anti-Bacterial Agents
La mucoviscidose. 22 années d'observation en pratique courante